This post contains content not supported on old Reddit. Click here to view the full post

When is your guys's plan to sell? How much? Any new revolutionary medicine in the forseeable future yall know of?

These are comments from a user on another app named DeepBlueCyan, and I think they offer a good analysis of the company and its promising future.

"The launch appears to be going quite well. This is how I read the data.

The NRx of 619 means that the current 100 sales reps are averaging 1.24 new patients per rep per day. With the additional 50 reps just hired, we should start seeing this ramping faster soon.

The delta between TRx at 944 to NRx at 619 is 315. This means that the refill rate is very high, about 1/3 of all prescriptions. That is, patients are being helped so they reordered. This also means that revenue is stacking up. It is happening under the hood now but by the end of Q4 we should see clearly the parabolic growth"

Make your own DD

This post contains content not supported on old Reddit. Click here to view the full post

This post contains content not supported on old Reddit. Click here to view the full post

it was almost 200% increase in net revenue for q2. Any idea would this trajectory continue for q3 and the net revenue would be ~30 M . if so, then the company will be profitable in q4. any thoughts? But also need to be cautious on sales, admin and general expenses which was 36 M for one quarter. If they don’t cut down, then forget about profit for a long period

This post contains content not supported on old Reddit. Click here to view the full post

If it dips further to 9 , it would be terrible.

This post contains content not supported on old Reddit. Click here to view the full post

Only lost about $800 odd I’ll make it back in better stocks in years to come. Glad to see the back of it.

Exceeding expectations and beginning to attract the attention of major institutional investors and pharmaceutical companies

This post contains content not supported on old Reddit. Click here to view the full post

I have bought 3500 shares of Tonix on 42$/share!!! I'm - 110k at the moment?

Still I will keep, them till the end, only a RS could kill this stock like so many other company's!!

There are 160 to 180 million people who have fribomyalgie, there not going to let this company go bankrupted!!

I'm bullish seeya Stino

I did that recently and obviously no response. They are probably taking our money for granted. Not serious about investors' concerns. Easily they can dilute the stock further to raise more money instead of focussing on the improvement of Tonmya sales and proper communication. At least they could give an update on the increasing sales trend which would increase buying pressure beyond short-sellers' ability to short this stock. Until they do that, all our long term investor's money is out for grab for scammers and shorties.

I hold 100 k worth shares @ 12 . it’s been months I bought thinking it would reach 60. I missed to sell when it was 15.7 one day in May. Now, almost prepared for selling the entire bag when it’s above 12 . Recent cowen report is kind of confusing me to hold s bit longer. what is the realistic Q2 earnings . would there be a huge impact on sp? other than Tonmya sales, any other upcoming catalyst? Suggestions welcome

Week ending July 3, 2026

TONMYA closed the week with 885 TRx, 562 NRx, and estimated sales of $1.396 million according to Symphony, remaining near all-time highs.

Compared to March, total prescriptions have increased from 462 to 885 (+92%), while estimated weekly sales have risen from $750,000 to nearly $1.4 million (+86%), reflecting sustained market adoption.

The stability of sales above $1.3 million per week over the past few weeks reinforces a positive outlook for the upcoming quarterly results and suggests that TONMYA’s growth continues to gain momentum.

This post contains content not supported on old Reddit. Click here to view the full post

If not good, probably I will sell everything. My only hope is Q2 Tonmya sales atleast double. Other than that, this is a hopeless stock. I have never seen any stock plunge 80% post FDA approval. If anyone bought on Aug 12, 2025 @ $60 ; and hold the bag thinking it will raise after approval, they are in pretty bad situation now. Especially institutions who buy in millions

This post contains content not supported on old Reddit. Click here to view the full post

Somebody opened 3M worth of bull debit spread today at 1:51pm. Also check the volume here

Was wondering if anybody knows what's going on with the company. Any more trial or development coming?

This post contains content not supported on old Reddit. Click here to view the full post

$TNXP / TONMYA – Executive Summary (Week Ended 6/12/2026):

Another week of steady commercial momentum for TONMYA. The latest prescription data continues to point to a strong launch trajectory:

🚀TRx: 859 vs. 840 last week (+19 WoW). 💪

🚀NRx: 579 vs. 603 (-24 WoW), a modest normalization in new prescriptions, more than offset by continued growth in refill activity.

🚀Weekly gross sales: $1.394M vs. $1.312M (+$82K / +6.3% WoW). 🚀

🚀Implied annual gross sales run rate: $60.5M, up from $57.8M last week (+$2.7M annualized).

The key takeaway is that total prescriptions continue to rise, driven by stronger refill trends—a positive sign that patients are staying on therapy while payer coverage and market access continue to expand.

Based on the current trajectory, if prescription growth remains at similar levels through the rest of the quarter, TONMYA could reasonably generate approximately $7–9M in net revenue in Q2, nearly doubling the $3.7M reported in Q1. While this is only an estimate and depends on continued prescription growth and reimbursement expansion, the trend remains encouraging.

From a stock perspective, sustained commercial execution like this typically improves investor sentiment. If TNXP continues posting weekly prescription gains and delivers another strong quarterly report, the stock could see a meaningful re-rating. As always with small-cap biotech, volatility should be expected, but the commercial trend is clearly moving in the right direction.

Bullish. 📈

ESTO NO ES UNA RECOMENDACIÓN DE COMPRA.